430 related articles for article (PubMed ID: 33272705)
1. Nuclear receptors in the kidney during health and disease.
Libby AE; Jones B; Lopez-Santiago I; Rowland E; Levi M
Mol Aspects Med; 2021 Apr; 78():100935. PubMed ID: 33272705
[TBL] [Abstract][Full Text] [Related]
2. Macrophage nuclear receptors: Emerging key players in infectious diseases.
Leopold Wager CM; Arnett E; Schlesinger LS
PLoS Pathog; 2019 Mar; 15(3):e1007585. PubMed ID: 30897154
[TBL] [Abstract][Full Text] [Related]
3. Role of nuclear receptors in the modulation of insulin secretion in lipid-induced insulin resistance.
Sugden MC; Holness MJ
Biochem Soc Trans; 2008 Oct; 36(Pt 5):891-900. PubMed ID: 18793157
[TBL] [Abstract][Full Text] [Related]
4. The Role of Nuclear Receptors in the Pathogenesis and Treatment of Non-alcoholic Fatty Liver Disease.
Yang Z; Danzeng A; Liu Q; Zeng C; Xu L; Mo J; Pingcuo C; Wang X; Wang C; Zhang B; Zhang B
Int J Biol Sci; 2024; 20(1):113-126. PubMed ID: 38164174
[TBL] [Abstract][Full Text] [Related]
5. The Therapeutic Role of Xenobiotic Nuclear Receptors Against Metabolic Syndrome.
Pu S; Wu X; Yang X; Zhang Y; Dai Y; Zhang Y; Wu X; Liu Y; Cui X; Jin H; Cao J; Li R; Cai J; Cao Q; Hu L; Gao Y
Curr Drug Metab; 2019; 20(1):15-22. PubMed ID: 29886826
[TBL] [Abstract][Full Text] [Related]
6. Nuclear receptors in acute and chronic cholestasis.
Gonzalez-Sanchez E; Firrincieli D; Housset C; Chignard N
Dig Dis; 2015; 33(3):357-66. PubMed ID: 26045270
[TBL] [Abstract][Full Text] [Related]
7. Anthranilic acid derivatives as nuclear receptor modulators--development of novel PPAR selective and dual PPAR/FXR ligands.
Merk D; Lamers C; Weber J; Flesch D; Gabler M; Proschak E; Schubert-Zsilavecz M
Bioorg Med Chem; 2015 Feb; 23(3):499-514. PubMed ID: 25583100
[TBL] [Abstract][Full Text] [Related]
8. Nuclear receptors and nonalcoholic fatty liver disease.
Cave MC; Clair HB; Hardesty JE; Falkner KC; Feng W; Clark BJ; Sidey J; Shi H; Aqel BA; McClain CJ; Prough RA
Biochim Biophys Acta; 2016 Sep; 1859(9):1083-1099. PubMed ID: 26962021
[TBL] [Abstract][Full Text] [Related]
9. Harnessing Oleanolic Acid and Its Derivatives as Modulators of Metabolic Nuclear Receptors.
Radwan MO; Kadasah SF; Aljubiri SM; Alrefaei AF; El-Maghrabey MH; El Hamd MA; Tateishi H; Otsuka M; Fujita M
Biomolecules; 2023 Sep; 13(10):. PubMed ID: 37892147
[TBL] [Abstract][Full Text] [Related]
10. Nuclear receptors in lipid metabolism: targeting the heart of dyslipidemia.
Beaven SW; Tontonoz P
Annu Rev Med; 2006; 57():313-29. PubMed ID: 16409152
[TBL] [Abstract][Full Text] [Related]
11. Roles of Nuclear Receptors in Esophageal Cancer.
Deng L; Liu J; Chen WD; Wang YD
Curr Pharm Biotechnol; 2023; 24(12):1489-1503. PubMed ID: 36740804
[TBL] [Abstract][Full Text] [Related]
12. Nuclear receptors in renal health and disease.
Luan ZL; Zhang C; Ming WH; Huang YZ; Guan YF; Zhang XY
EBioMedicine; 2022 Feb; 76():103855. PubMed ID: 35123268
[TBL] [Abstract][Full Text] [Related]
13. Novel insights into the regulation of cellular catabolic metabolism in macrophages through nuclear receptors.
Stifel U; Caratti G; Tuckermann J
FEBS Lett; 2022 Oct; 596(20):2617-2629. PubMed ID: 35997656
[TBL] [Abstract][Full Text] [Related]
14. Bile Acid-Activated Receptors: A Review on FXR and Other Nuclear Receptors.
Shin DJ; Wang L
Handb Exp Pharmacol; 2019; 256():51-72. PubMed ID: 31230143
[TBL] [Abstract][Full Text] [Related]
15. System analysis of cross-talk between nuclear receptors reveals an opposite regulation of the cell cycle by LXR and FXR in human HepaRG liver cells.
Wigger L; Casals-Casas C; Baruchet M; Trang KB; Pradervand S; Naldi A; Desvergne B
PLoS One; 2019; 14(8):e0220894. PubMed ID: 31437187
[TBL] [Abstract][Full Text] [Related]
16. Liver X receptor and peroxisome proliferator-activated receptor as integrators of lipid homeostasis and immunity.
Kidani Y; Bensinger SJ
Immunol Rev; 2012 Sep; 249(1):72-83. PubMed ID: 22889216
[TBL] [Abstract][Full Text] [Related]
17. Lipid-sensing nuclear receptors in the pathophysiology and treatment of the metabolic syndrome.
Vacca M; Degirolamo C; Mariani-Costantini R; Palasciano G; Moschetta A
Wiley Interdiscip Rev Syst Biol Med; 2011; 3(5):562-87. PubMed ID: 21755605
[TBL] [Abstract][Full Text] [Related]
18. Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with type 1 diabetes.
Proctor G; Jiang T; Iwahashi M; Wang Z; Li J; Levi M
Diabetes; 2006 Sep; 55(9):2502-9. PubMed ID: 16936198
[TBL] [Abstract][Full Text] [Related]
19. Role of Class II nuclear receptors in liver carcinogenesis.
Li G; Guo GL
Anticancer Agents Med Chem; 2011 Jul; 11(6):529-42. PubMed ID: 21554208
[TBL] [Abstract][Full Text] [Related]
20. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling.
Ide T; Shimano H; Yoshikawa T; Yahagi N; Amemiya-Kudo M; Matsuzaka T; Nakakuki M; Yatoh S; Iizuka Y; Tomita S; Ohashi K; Takahashi A; Sone H; Gotoda T; Osuga J; Ishibashi S; Yamada N
Mol Endocrinol; 2003 Jul; 17(7):1255-67. PubMed ID: 12730332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
